MFRHX
Price
$63.37
Change
+$0.64 (+1.02%)
Updated
Oct 20 closing price
Net Assets
8.09B
VSTSX
Price
$317.21
Change
+$3.54 (+1.13%)
Updated
Oct 20 closing price
Net Assets
2.02T
Interact to see
Advertisement

MFRHX vs VSTSX

Header iconMFRHX vs VSTSX Comparison
Open Charts MFRHX vs VSTSXBanner chart's image
MFS Research R3
Price$63.37
Change+$0.64 (+1.02%)
VolumeN/A
Net Assets8.09B
Vanguard Total Stock Mkt Idx Instl Sel
Price$317.21
Change+$3.54 (+1.13%)
VolumeN/A
Net Assets2.02T
MFRHX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
MFRHX vs. VSTSX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFRHX is a StrongBuy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.02T vs. MFRHX (8.09B). VSTSX pays higher dividends than MFRHX: VSTSX (1.15) vs MFRHX (0.41). MFRHX was incepted earlier than VSTSX: MFRHX (21 years) vs VSTSX (9 years). MFRHX (0.77) is less costly to investors than VSTSX (0.01). MFRHX is a more actively managed with annual turnover of: 20.00 vs. VSTSX (2.00). MFRHX has a lower initial minimum investment than VSTSX: MFRHX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 14.67 vs. MFRHX (1.43). VSTSX return over 5 years is better than : 89.91 vs. MFRHX (31.90).
MFRHXVSTSXMFRHX / VSTSX
Total Expense Ratio0.770.017,700%
Annual Report Gross Expense Ratio0.770.017,700%
Fund Existence21 years9 years-
Gain YTD11.02014.30577%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.09B2.02T0%
Annual Yield % from dividends0.411.1536%
Returns for 1 year1.4314.6710%
Returns for 3 years34.0077.0944%
Returns for 5 years31.9089.9135%
Returns for 10 years75.63N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDMT11.271.43
+14.53%
4D Molecular Therapeutics
INDP3.900.20
+5.41%
Indaptus Therapeutics Inc
APPN29.211.06
+3.77%
Appian Corp
LGO1.330.04
+3.10%
Largo
IONS73.550.46
+0.63%
Ionis Pharmaceuticals